title: Pneumocystis jiroveci Pneumonia in an Atypical Host.
authors: Department of Internal Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA. Raquel.Reinbolt@osumc.edu
authors: Raquel E
authors: RE
authors: Reinbolt
authors: Shadia
authors: S
authors: Alam
authors: Rachel
authors: R
authors: Layman
authors: Charles
authors: C
authors: Shapiro
authors: Maryam
authors: M
authors: Lustberg
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D018791:CD4 Lymphocyte Count; D017321:Clinical Trials, Phase I as Topic; D003907:Dexamethasone / Q000627:therapeutic use; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D011799:Quinazolines / Q000008:administration & dosage; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000890:Anti-Infective Agents; D061067:Antibodies, Monoclonal, Humanized; D009588:Nitrogen Mustard Compounds; D011799:Quinazolines; D000068258:Bevacizumab; D003907:Dexamethasone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000069461:Bendamustine Hydrochloride; D000069347:Erlotinib Hydrochloride; D017239:Paclitaxel